/ 333 Shares
05-Jun-2026 - 09-Jun-2026
₹ 42 - ₹ 45
₹ 14985.00
333
30,859,704
Face Value - ₹ 1/- Per Share
Listing at NSE BSE
32,435 Application Required in Retail for 1 Time.
Registrar : KFin Technologies Limited
Offer for sale of 30,859,704 Equity Shares
| Category | % | Shares/Amount |
|---|---|---|
| QIB | 50% | 15,429,852 Shares RS.69.43 CR |
| HNI 1 | 5% | 1,542,985 Shares RS.6.94 CR @ 331 FORM 1X |
| HNI 2 | 10% | 3,085,970 Shares RS.13.89 CR @ 662 FORM 1X |
| Retail | 35% | 10,800,897 Shares RS.48.60 CR @ 32435 FORM 1X |
BRLMs: Cumulative Capital Pvt. Ltd, Catalyst Capital Partners Pvt. Ltd
| Retail (Upto 2 Lakh) | HNI (2 Lakh to 10 Lakh) | HNI (Above 10 Lakh) |
|---|---|---|
| 32435 FORM 1X | 331 FORM 1X | 662 FORM 1X |
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Upto 2 Lakh) | 1 | 333 | ₹ 14,985 |
| Retail (Upto 2 Lakh) | 13 | 4329 | ₹ 194,805 |
| S-HNI (2 Lakh to 10 Lakh) | 14 | 4662 | ₹ 209,790 |
| S-HNI (2 Lakh to 10 Lakh) | 66 | 21978 | ₹ 989,010 |
| B-HNI (Above 10 Lakh) | 67 | 22311 | ₹ 1,003,995 |
05-Jun-2026 16:39
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 6,171,941 ₹ 27.77 Cr. | 0 ₹ 0.00 Cr. | 0.00x |
| HNI (<10 LAKH) | 1,542,985 ₹ 6.94 Cr. | 5,201,127 ₹ 23.41 Cr. | 3.37x |
| HNI2 (>10 LAKH) | 3,085,970 ₹ 13.89 Cr. | 3,990,006 ₹ 17.96 Cr. | 1.29x |
| RETAIL | 10,800,897 ₹ 48.60 Cr. | 25,437,537 ₹ 114.47 Cr. | 2.36x |
| Total | 21,601,793 | 34,628,670 | 1.60x |
| Category | Book Size | Subscription | No. of Times |
|---|---|---|---|
| QIB | 6,171,941 ₹ 27.77 Cr. | 0 ₹ 0.00 Cr. | 0.00x |
| HNI (<10 LAKH) | 1,542,985 ₹ 6.94 Cr. | 5,201,127 ₹ 23.41 Cr. | 3.37x |
| HNI2 (>10 LAKH) | 3,085,970 ₹ 13.89 Cr. | 3,990,006 ₹ 17.96 Cr. | 1.29x |
| RETAIL | 10,800,897 ₹ 48.60 Cr. | 25,437,537 ₹ 114.47 Cr. | 2.36x |
| Total | 21,601,793 | 34,628,670 | 1.60x |
*Excluding Anchor
Total No. of Application Approx : ~59526 (1.84 Appwise)
| Appwise Subscription | ||
|---|---|---|
| Category | Total App | App wise |
| HNIBT | 1000.21 331 (For 1x) | 3.02x |
| HNIAT | 114.10 662 (For 1x) | 0.17x |
| RETAIL | 19358.00 32435 (For 1x) | 0.60x |
Disclaimer: The above-mentioned information / data are sourced from the websites of National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) and are subject to change on real time basis. For updated information / data you can visit their respective website. The information / data provided herein above are for information purpose only and provided "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied. We do not guarantee or warrant the accuracy, adequacy or completeness of the information received through the said websites. “We” hold not responsibility of any kind as regard to any discrepancies, errors, omissions, losses or damages. “We” including its affiliates and any of its officers, directors, personnel and employees, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of information / data received through the said websites. The recipient alone shall be fully responsible / are liable for any decision taken on the basis of such information / data. All recipients should before acting upon the said information make their own investigation, seek appropriate professional advice.
Incorporated in 1993, Hexagon Nutrition is a differentiated and research-oriented
pure play nutrition Company which offers products across a whole range starting
with micronutrient premixes, right up to therapeutic and clinical products.
? The company is also one of the largest premix players in India, offering customised
vitamin and mineral premixes to leading Indian and multinational FMCG
companies. It is also one of the largest licensed suppliers of Micronutrient Powders
(MNPs) under UN programmes, supporting global food fortification and public
health initiatives.
? The company’s product portfolio addresses a broad spectrum of nutritional aspects
such as fortification of foods, therapeutic nutrition, clinical nutrition and alleviation
of malnutrition.
? The company started as a micronutrient formulations player and has since steadily
progressed up the value chain, developing its brands such as “PENTASURE”,
“OBESIGO” and “PEDIAGOLD” in the health, wellness and clinical nutrition space.
In FY 2024, the company further expanded its portfolio with the launch of a new
brand, “NUTRONE”, strengthening its position in the segment.
? The company operates 3 manufacturing facilities in India, located in Nasik
(Maharashtra), Chennai (Tamil Nadu) and Thoothukudi (Tamil Nadu), along with 1
international manufacturing facility in Tashkent, Uzbekistan.
? The company’s manufacturing facilities have received various certifications and
accreditations, including the FSSC 22000, Good Manufacturing Practice (GMP)
certification, ISO 9001:2015 Certification, and Halal Certification, amongst others
from various local and international accreditation agencies.
? The Company has a PAN-India omnichannel distribution network, supported by its
presence across retail pharmacies, hospital networks, e-commerce platforms, and
its own websites, including www.pentasurenutrition.com,www.obesigo.com,
www.pediagold.com and www.nutrone.fit.
? The Company’s distribution network comprises 20 non-exclusive regional
distributors across North and South America, Southeast Asia, Africa, and the Middle
East. In addition, the Company maintains 3 overseas offices located in South Africa,
Uzbekistan and Hong Kong, which support its international business operations.
? The Company exported its products to more than 75 countries, including South
Africa, Malaysia, Ethiopia, France, French Polynesia, Ghana, Indonesia, Kenya,
Madagascar, Mozambique, Papua New Guinea, Nigeria, Philippines, Qatar, UAE,
Mauritius and Brazil, among others.
? The Company has exhibited steady growth, with revenue increasing from ?278.50
crore in FY23 to ?324.93 crore in FY25 (?267.59 crore for 9M FY26), while profit after
tax increased significantly from ?5.82 FY23 crore to ?24.38 crore FY25 (?27.03 crore
in 9M FY26), indicating strong scalability and profitability.
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total Income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| NET Worth | 223.05 | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 210.92 | 183.89 | 164.51 | 152.30 |
| Total Borrowing | 39.79 | 26.60 | 36.89 | 51.87 |
| Amount in ? Crore | ||||
Once you create your account, Login to Us.
Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Enter your UPI ID and you will receive mandate on your UPI App.
Once you accept the mandate, Application is submitted successful.
How to Apply for IPOs on Easy Investing
Step 01 : Once you create your account, Login to your acount.
Step 02 : Under IPO Section, you will be able to see a list of Ongoing IPOs, where you can click on apply button.
Step 03 : Add quantity of shares to apply – Maximum 3 bids are allowed (For retail category – max amount Rs.2,00,000/-).
Step 04 : Enter your UPI ID and you will receive mandate on your UPI App.
Step 05 : Once you accept the mandate, Application is submitted successful.
